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S U M M A R Y
Background: Device-associated infections (DAI) are recognized as a marker of patient safety. Data
regarding DAI rates in Saudi Arabia are sparse.
Methods: This was a prospective surveillance study of DAI rates conducted in the adult intensive care
units of the Saudi Aramco Medical Services Organization, carried out using the DAI deﬁnition provided
by the Centers for Disease Control and Prevention’s National Healthcare Safety Network. DAI prevention
bundles were introduced in 2006 for ventilator-associated pneumonia (VAP), in mid-2010 for catheter-
associated urinary tract infections (CAUTI), and in 2008 for central line-associated blood stream
infections (CLABSI).
Results: DAI rates for VAP, CLABSI, and CAUTI are reported for the study period from 2004 to 2011. CAUTI
was the most common DAI (42.2%), followed by CLABSI (38.5%) and VAP (19.3%). The overall rate of each
infection type per 1000 device-days was 8.18 for CAUTI, 10 for CLABSI, and 4.52 for VAP. Annual DAI rates
showed a signiﬁcant reduction over time from the beginning of the study to the end of the study for
CLABSI (16.3 vs. 6.06), CAUTI (6.75 vs. 3.41), and VAP (9.8 vs. 1.3) (p < 0.05).
Conclusions: CAUTI was the most common infection, and the use of DAI prevention bundles was
associated with a signiﬁcant decrease in DAI rates over time.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Device-associated infections (DAIs) are associated with an
increased length of hospital stay, added costs, and increased
morbidity and mortality.1,2 Measurements and improvements in
DAI are important quality improvements and patient safety goals
as set by international organizations such as the Infectious
Diseases Society of America (IDSA) and the Society for Healthcare
Epidemiology of America (SHEA).3 The most commonly used
program for inter-hospital comparison is the National Healthcare
Safety Network (NHSN).4 The utilization of NHSN identiﬁes areas
to target for future improvements rather than just providing a
comparison.5 A previous study showed no signiﬁcant difference in
catheter-associated blood stream infection (CLABSI) rates between* Corresponding author. Tel.: +966 3 877 3524; fax: +966 3 877 3790.
E-mail addresses: jaffar.tawﬁq@aramco.com, jaltawﬁ@yahoo.com
(J.A. Al-Tawﬁq).
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http://dx.doi.org/10.1016/j.ijid.2013.06.015non-US and US hospitals.6 Other studies have shown variations in
the rates of DAI between the NHSN data and the International
Nosocomial Infection Control Consortium (INICC).7 These differ-
ences were thought to be secondary to inadequate compliance
with infection control guidelines, low compliance with hand
hygiene, and a lack of administrative and ﬁnancial support.7
There are few data regarding DAI rates in Saudi Arabia. Studies
have been limited to a speciﬁc unit or to a speciﬁc device.8–11 One
study included multiple DAI rates from various units.11 Thus, we
undertook this prospective study to evaluate the trends in DAI over
time and to calculate the impact of the implementation of bundles
for the prevention of DAI.
2. Materials and methods
The study was conducted in the adult intensive care units of the
Saudi Aramco Medical Services Organization (SAMSO). SAMSO has
a 10-bed medical ICU (MICU), a 10-bed surgical ICU (SICU), and an
eight-bed coronary ICU (CCU). We collected data related to deviceses. Published by Elsevier Ltd. All rights reserved.
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each unit.
2.1. Deﬁnition of device-associated healthcare-associated infections
(DA-HAI)
The diagnosis of DAI was based on the NHSN deﬁnitions.4 The
speciﬁc criteria for each diagnosis of DA-HAI are listed below.
VAP was identiﬁed using a combination of radiologic, clinical,
and laboratory criteria. VAP was considered present in patients on
mechanical ventilation with a chest X-ray showing a new or
progressive inﬁltrate, consolidation, cavitation, or pleural effusion.
Clinical criteria included at least one of the following: new onset of
purulent sputum, a change in character of sputum, and isolation of
a bacterial agent from tracheal aspirate/brushing or bronchoal-
veolar lavage.
CLABSI was deﬁned as a laboratory-conﬁrmed infection in a
patient with a central line in place for 48 h who had a recognized
pathogen isolated from one or more percutaneous blood cultures,
and when the infection was not related to an infection at another
site. Isolation of the same organism (i.e., identical species and
antibiogram) from a semi-quantitative or quantitative culture of a
catheter segment and from the blood (preferably drawn from a
peripheral vein) of a patient with accompanying clinical symptoms
of BSI (fever >38 8C, chills, or hypotension) and no other apparent
source of infection was required. For common skin contaminants
including diphtheroids (Corynebacterium spp), Bacillus spp (not
Bacillus anthracis), Propionibacterium spp, coagulase-negative
staphylococci (including Staphylococcus epidermidis), viridans
group streptococci, Aerococcus spp, and Micrococcus spp, two or
more blood cultures drawn on separate occasions were required to
be positive.
CAUTI was deﬁned in a patient with a urinary catheter in place
exhibiting either one of the following two criteria: (1) one or more
of the following signs and symptoms with no other recognized
cause: fever (temperature >38 8C), urgency, supra-pubic tender-
ness, and urine culture 105 CFU/ml, with no more than two
species of microorganism isolated; or (2) positive dipstick
analysis for leukocyte esterase or nitrate and pyuria (urine
specimen with 10 white blood cells/mm3 or 3 white blood
cells/high-power ﬁeld of unspun urine), microorganisms seen onTable 1
Central line-associated blood stream infections (CLABSI) and device utilization ratios in 
Network (NHSN) data (from reference 15)
Variable Study data 
Total 95% CI 10th
Cardiac care unit
No. of device-days 4133 
No. of patient-days 15 733 
No. of infections 37 
Device utilization ratio 0.26 0.18–0.33 0.18 
CLABSI rate/1000 catheter-days 8.95 3.07–15.77 3.93 
Surgical ICU
No. of device-days 8833 
No. of patient-days 14 299 
No. of infections 48 
Device utilization ratio 0.62 0.5–0.73 0.46 
CLABSI rate/1000 catheter-days 5.43 2.47–8.88 2.25 
Medical ICU
No. of device-days 8528 
No. of patient-days 18 129 
No. of infections 130 
Device utilization ratio 0.47 0.41–0.54 0.39 
CLABSI rate/1000 catheter-days 15.24 11.93–18.32 11.52 
ICU, intensive care unit.Gram stain of unspun urine, and a positive urine culture of 103
and <105 CFU/ml with no more than two species of microorgan-
ism isolated
2.2. Device utilization ratio (DUR) and DA-HAI rates
The device utilization ratio (DUR) for each device (central line,
ventilator, and urinary catheter) was calculated as the number of
device-days divided by the total number of patient-days in each
ICU. DAI rates per 1000 device-days were calculated as the number
of infections for each device divided by the total number of device-
days in each ICU. Thus, risk adjustment was done by type of ICU,
type of invasive device, and by adjusting the rate per 1000 device-
days.3,10 Data were collected from January 2004 to December 2011.
Annual trends were presented for each type of DAI. A p-value of
0.05 was considered signiﬁcant.
The bundle for CAUTI was implemented in mid-2010 and that
for CLABSI was started in 2008. The bundles were those of the
Institute for Healthcare Improvement.12–14 In addition, the
interventions included a multifaceted approach to the prevention
of HAI and included education of healthcare workers about HAI and
the bundle, implementation of the bundle, surveillance and
feedback of HAI on a monthly basis through direct communication
as well as dissemination of information through the hospital
intranet, and feedback on compliance with the bundles.
2.3. Statistical analysis
Data analyses were done using PASW Statistics for Windows,
version 18.0 (SPSS Inc., Chicago, IL, USA). To compare the trends in
the infection rates over the years, we used the comparison of more
than two samples proportion test. To compare the means of two
different times, we used the comparison of two samples means
using the t-test.
3. Results
During the study period of 2004–2011, CAUTI was the most
common DAI (42.2%), followed by CLABSI (38.5%) and VAP (19.3%).
The overall rate of each infection type per 1000 device-days was
8.18 for CAUTI, 10 for CLABSI, and 4.52 for VAP. The CLABSI rate wasthree adult intensive care units, and a comparison with National Healthcare Safety
NHSN data
50th 90th Total 10th 50th 90th
436 409
1 096 749
876
0.24 0.36 0.4 0.18 0.39 0.61
7.54 17.38 2.01 0 1.3 4.6
729 989
1 230 430
1683
0.63 0.77 0.59 0.35 0.62 0.77
5.75 9.03 2.31 0 1.7 5
362 388
801 740
687
0.5 0.55 0.45 0.14 0.44 0.69
14.98 18.66 1.9 0 1 4.3
Table 2
Ventilator-associated pneumonia (VAP) and device utilization ratios in three adult intensive care units, and a comparison with National Healthcare Safety Network (NHSN)
data (from reference 15)
Variable Study data NHSN data
total 95% CI 10th 50th 90th total 10th 50th 90th
Cardiac care unit
No. of ventilator-days 3607 174 480
No. of patient-days 15 830 636 144
No. of infections 7 366
Device utilization ratio 0.23 0.19–0.25 0.18 0.24 0.26 0.27 0.09 0.25 0.46
VAP rate/1000 ventilator-days 1.94 0–3.7 0 0.91 4.93 2.1 0 1.2 5.8
Surgical ICU
No. of ventilator-days 8295 311 739
No. of patient-days 14 351 802 912
No. of infections 41 1515
Device utilization ratio 0.58 0.48–0.66 0.45 0.57 0.67 0.39 0.21 0.37 0.58
VAP rate/1000 ventilator-days 4.94 2.05–8.37 2.41 3.89 9.59 4.86 0 3.8 9.9
Medical ICU
No. of ventilator-days 11 987 181 102
No. of patient-days 18 265 498 463
No. of infections 60 398
Device utilization ratio 0.66 0.60–0.69 0.59 0.67 0.71 0.36 0.07 0.34 0.54
VAP rate/1000 ventilator-days 5.01 0.40–9.39 0.55 2.66 12.7 2.2 0 1.3 6.1
ICU, intensive care unit.
Table 3
Catheter-associated urinary tract infection (CAUTI) and device utilization ratios in three adult intensive care units, and a comparison with National Healthcare Safety Network
(NHSN) data (from reference 15)
Variable Study data NHSN data
Total 95% CI 10th 50th 90th Total 10th 50th 90th
Cardiac care unit
No. of device-days 6156 302 388
No. of patient-days 15 902 536 190
No. of infections 43 1457
Device utilization ratio 0.39 0.31–0.47 0.26 0.43 0.48 0.56 0.29 0.62 0.78
CAUTI rate/1000 catheter-days 6.99 3.95–10.78 3.73 6.4 11.47 4.82 0 4.1 9.4
Surgical ICU
No. of device-days 9984 474 506
No. of patient-days 14 497 588 523
No. of infections 66 2033
Device utilization ratio 0.69 0.50–0.91 0.43 0.82 0.94 0.81 0.63 0.82 0.94
CAUTI rate/1000 catheter-days 6.61 3.58–10.15 3.62 6.06 11 4.28 0.7 3.4 9.1
Medical ICU
No. of device-days 12 719 289 636
No. of patient-days 18 466 389 379
No. of infections 127 1135
Device utilization ratio 0.69 0.62–0.76 0.61 0.68 0.78 0.74 0.47 0.73 0.9
CAUTI rate/1000 catheter-days 9.99 7.02–13.17 6.21 10.14 13.15 3.92 0 3 8.2
ICU, intensive care unit.
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Figure 1. Line graph showing the device-associated infection rates over time (2004–
2011) for catheter-associated urinary tract infection (CAUTI), central line-associated
blood stream infection (CLABSI), and ventilator-associated pneumonia (VAP).
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(5.43) (Table 1)
DAI rates in the present study were compared to the rates in
the NHSN data. For CAUTI, the rates in the CCU and SICU were
more than the 50th percentile of the NHSN data and were more
than the 90th percentile for the MICU. VAP rates were 5.01 in the
MICU, 4.94 in the SICU, and 1.94 in the CCU (Table 2). CAUTI rates
were 9.99 in the MICU, 6.99 in the CCU, and 6.61 in the SICU
(Table 3). Annual DAI rates showed a signiﬁcant reduction over
time for CLABSI (16.3 vs. 6.06), p = 0.002; CAUTI (6.75 vs. 3.41), p =
0.04; and VAP (9.8 vs. 1.3), p < 0.001 (Figure 1). The resulting
reductions in DAI rates were 86.7% for VAP, 63% for CABSI, and
50% for CAUTI.
The reduction in the trend in the infection rates over the years
for CAUTI, CLABSI, and VAP was statistically signiﬁcant (p < 0.001).
However, a comparison of the mean infection rates for DAI before
and after the implementation of the bundles was not statistically
signiﬁcant (Table 4). Compliance with the different elements of the
bundles was about 95%, except for the selection of the optimal site
for central line, which was 85%.
Table 4
Comparison of device-associated infection rates in two periods, before bundle implementation and after bundle implementation
Before bundle After bundle p-Value
Mean SD Mean SD
CLABSI 9.24 2.47 5.45 2.89 0.118
Central line utilization ratio 0.59 0.11 0.61 0.18 0.118
CAUTI 11.32 3.51 8.71 2.65 0.280
Urinary catheter utilization ratio 0.40 0.07 0.49 0.05 0.069
VAP 8.98 1.05 1.94 0.73 <0.001
Endotracheal ventilation utilization ratio 0.47 0.06 0.50 0.05 0.455
SD, standard deviation; CLABSI, central line-associated blood stream infections; CAUTI, catheter-associated urinary tract infection; VAP, ventilator-associated pneumonia.
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DAI rates in the present study were compared to the rates in the
NHSN data.4 For CAUTI, the rates in the CCU and SICU were higher
than the 50th percentile of the NHSN data and were higher than the
90th percentile for the MICU. We also observed higher rates for
CLABSI than the corresponding rates in the NHSN. The pooled
CLABSI rate of 10/1000 device-days in the present study is higher
than the pooled rate of 6.8/1000 device-days in ICUs in the INICC
report and the NHSN study.4,15 The overall VAP rate in the present
study was similar to that of the NHSN report (4.5 vs. 3.3/1000
device-days), and much lower than the INICC rate of 15.8.7 In
addition, the pooled CAUTI rate (8.2/1000 device-days) is closer to
the INICC rate (6.3/1000 device-days)7 and higher than the NSHN
data.15 In the surveillance program of nosocomial infections in
Catalonia (VINCat Program), the incidence rates of VAP ranged
from 7.2 to 10.7 episodes/1000 ventilator-days, and the rate of
CLABSI ranged from 1.9 to 2.7 episodes/1000 central venous
catheter-days.16 The variation in the DAI rates between the
different studies cited could be related to the difference in the
setting of the involved hospitals and the different application of
preventive measures, e.g., bundles, in many hospitals in the USA.
It was estimated that DAI can be reduced by 30%.7 In this study,
DAI rates were reduced by 50% to 87% over the study period, as
noted previously.17 The institution of DAI surveillance is a
recognized measure to reduce these infections.18 More recently
the emergence of the bundle concepts has added value to the scope
of improvement and reduction in the rates of DAIs. In a recent
study from Saudi Arabia, the VAP rate was 19.1 per 1000
ventilator-days in 2003 and decreased to 6.3 per 1000 ventila-
tor-days in 2009.19 We previously showed that the application of
the VAP bundle resulted in a signiﬁcant reduction in the rates of
VAP over time.20 That study was conducted in 2006 to 2008 and
since then the rate of VAP has remained low at 1.3 per 1000 device-
days compared to 2.2 per 1000 device-days in 2008.20 Thus, it is
possible to maintain a low rate of VAP over time with diligent
application and incorporation of the bundle in the daily routine, as
well as an increase in the rate of compliance with hand hygiene.21
In a previous study from our hospital for the period 2004–2006, the
rate of CLABSI per 1000 device-days for all ICUs including the
neonatal ICU was 9.4 in 2004, 11.7 in 2005, and 8.2 in 2006 (p =
0.083).22 In the current study, the CLABSI rate decreased from 16.3
to 6.06 per 1000 device-days (p = 0.002) after implementation of
the CLABSI prevention bundle. In addition, during the study period
the overall hospital compliance with hand hygiene increased from
40% in 2004 to 85% in 2011.21
The emergence of the bundle concepts resulted in an additional
reduction in the DAI rates. The data in the current study did not
show a statistically signiﬁcant reduction in the DAI rates before
and after implementation of the bundles. This is likely related to
the short period of time that has passed since the bundle
implementation period. The study clearly showed that the
implementation of an infection control program with feedbackresulted in a time-trend reduction in DAI. Previous studies have
shown the effectiveness of the implementation of bundles within a
multidimensional approach.23–25 The differences between these
studies and our study are the inclusion of far greater numbers of
DAIs and the involvement of multiple hospitals. This is substanti-
ated by the fact that in the current study, there was a linear trend
showing an overall reduction in CLABSI, CAUTI, and VAP rates at
the end of the study compared to the rates at the beginning of the
study.
Of importance, the present study provides a description of DAIs
in a hospital in Saudi Arabia and shows that DAIs can be reduced
over time by at least 50%. The systematic collection of data and the
actions taken to reduce DAIs will further decrease the burden of
HAIs and improve patient safety. The current study was based in
one hospital (an admitted limitation), but included multiple ICUs
and covered a period of over 8 years. Other limitations include the
non-availability of patient characteristics and the absence of data
on microorganism proﬁles and bacterial resistance.
In conclusion, studies on the epidemiology of DAIs are
warranted to further reduce infection rates. It is possible to reduce
these rates through the systematic collection, analysis, and
utilization of quality improvement techniques and methodologies.
Future infection control activities should be directed towards
further reductions in DAIs, especially CLABSI, in our institution.
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